Pre-Workout Peptide Timing and the GH Pulse

The Exercise GH Pulse

Lifters who take a peptide before they lift usually want to line it up with the body's own hormonal response to training. When you train hard (heavy squats, intense supersets with short rest), your pituitary gland releases a pulse of growth hormone (GH). This is called the exercise-induced growth hormone response (EIGR). A 2005 review found that GH stays raised for 15-30 minutes after a demanding resistance session, with the biggest rises after high-volume, short-rest workouts.

Whether that pulse is a key signal for recovery and growth is less clear. In a 2010 McMaster University study, 12 young men trained each arm separately for 15 weeks, one arm with a large post-exercise hormone rise and one without. Muscle size and strength rose about equally in both. Our overview of what is and isn't known about dose timing covers that study in more detail.

This is where peptides like GHRHs (Growth Hormone Releasing Hormones) and GHRPs (Growth Hormone Releasing Peptides) come in. Users think of them as amplifiers for a signal that's already there. A GHRH like CJC-1295 no DAC mimics the hormone that tells your pituitary to release GH, while a GHRP like Ipamorelin acts on the ghrelin receptor and appears to work partly by opposing somatostatin, the hormone that tells your body to stop releasing GH. A 2018 review notes that the GH release these secretagogues produce stays pulsatile and subject to normal feedback.

The pre-workout idea is that the peptide-induced pulse and the exercise-induced pulse should hit at the same time. Small IV studies have tested that pairing. In a 1997 Utrecht study of 11 fasted young men, 100 mcg of GHRP-6 given with cycling had additive effects on GH peak size. In a 2000 study from the same group, GHRH (100 mcg) and GHRP-2 (200 mcg) given during cycling produced GH responses that didn't differ significantly from adding up each separate stimulus. So you're getting roughly Pulse A plus Pulse B, not a pulse that's far greater than the sum of its parts. Nobody has repeated this with subcutaneous ipamorelin or Mod GRF 1-29 before lifting, and no study has shown that the extra GH changes muscle or strength.

Reported Timing by Peptide Class

Not all peptides show up in pre-workout protocols, and users widely avoid one class before training.

GHRHs & GHRPs: The 30-Minute Window

This is the most common pre-workout stack in forum guides: a GHRH (like CJC-1295 no DAC, also known as Mod GRF 1-29) combined with a GHRP (like Ipamorelin or GHRP-2).

The window users most often describe is 30 to 45 minutes pre-workout. Community guides say a subcutaneous injection of these peptides peaks in about 30 minutes, and that you want that peak to coincide with your first few heavy work sets, when your body's own EIGR is kicking into gear. We couldn't find a study that measured the GH peak after a subcutaneous dose. In a 1999 study of healthy men, a 15-minute IV ipamorelin infusion produced a GH burst that peaked about 40 minutes after it started, but subcutaneous absorption is slower, so the real overlap is unknown.

Forum guides commonly describe 100 mcg of CJC-1295 no DAC with 100-200 mcg of Ipamorelin per pre-workout dose. That's community practice, not a tested protocol.

BPC-157 & TB-500: The Tissue Prep Protocol

These are a different case entirely. Peptides like BPC-157 and TB-500 (a seven-amino-acid fragment of thymosin beta-4, not the full protein) aren't about an acute GH pulse. In preclinical studies, BPC-157 has been linked to angiogenesis (the formation of new blood vessels) and lower inflammation. A 2025 systematic review found that 35 of its 36 included studies were preclinical, with no clinical safety data. For the TB-500 fragment, FDA said in April 2026 that it had found no human exposure data.

The logic users give for pre-workout use is to increase blood flow to the muscles and connective tissues you're about to load. For these, the timing is treated as less critical, and users most often describe 60 to 90 minutes pre-workout. No study has tested this, and the same review reports a BPC-157 half-life under 30 minutes. Users mostly describe this approach when they're rehabbing a nagging tendon or joint issue.

Why Users Avoid IGF-1 LR3 Pre-Workout

Most user guides warn against IGF-1 LR3 or IGF-1 DES before a workout. IGF-1 is the hormone downstream from GH, and like insulin it lowers blood sugar. Users report hypoglycemia (low blood sugar) as the most common acute problem with IGF-1 LR3, and low blood sugar can bring dizziness and weakness, a real hazard with a loaded bar on your back. No human trial has tested IGF-1 LR3 at any dose. People who use it generally take it after training, which we cover in our guide to post-workout peptide timing.

The Arch-Nemesis of Your GH Pulse: Food

User guides stress food most, and here the physiology backs them up.

When blood sugar is high, GH secretion is inhibited. In a 1995 study of six healthy men, a 100 g glucose drink almost abolished the GH response to IV GHRH, cutting the peak from about 20 to about 6 mcg/L. The same drink only blunted the response to hexarelin (a GHRP), and an IV fat infusion had nearly the same split. Fat blunts the exercise pulse too: raising blood fatty acids blocked it in a 1981 cycling study, and a high-fat meal 45 minutes before exercise cut it by about 75% in obese children in 2012. On that evidence, a shot of CJC/Ipamorelin 30 minutes after a banana and a scoop of whey is like hitting the gas and the brakes at the same time, at least for the GHRH half of the stack.

These studies mostly used glucose drinks or IV fat and IV peptides, so they support keeping food away from the dose without establishing a specific fasting window. Our page on meal timing and peptides goes further into the food question. Users handle it in two ways:

• Fasted Training: Many users dose first thing in the morning on an empty stomach and train about 30 minutes later. They describe this as the cleanest GH pulse, though no study has compared it with fed training.
• Fed Training: Users who train later in the day commonly describe waiting at least 2-3 hours after their last meal before dosing, to give blood glucose and insulin time to return toward baseline. No study has tested that window.

Commonly Reported Pre-Workout Timelines

The table puts user practice into a simple timeline, with two paths depending on when people train. It reflects forum and vendor guidance, not a tested protocol.

What we still don't know

• As of October 2026, we found no study of subcutaneous GHRH or GHRP doses timed before resistance training, whether measuring GH levels or muscle outcomes.
• The IV studies show exercise and peptide GH responses roughly adding together in the blood. The 2010 McMaster study suggests short exercise-related hormone rises don't add muscle or strength, so a bigger pulse may not mean better results.
• User guides credit pre-workout dosing with fuller pumps and better nutrient partitioning; we found no study that measured either.
• A pre-workout dose on top of the bedtime doses many users take may blunt later responses. In a 2004 study, GHRH given two hours after a maximal IV dose of GHRH plus hexarelin produced little GH, which the authors read as desensitization. Whether typical subcutaneous doses do this is unknown.